Author: franperez66q@protonmail.com

Morgan Stanley’s office in Canary Wharf financial district on Jan. 30, 2025 in London, UK.Mike Kemp | In Pictures | Getty ImagesMorgan Stanley will soon open a key wealth management funnel to artificial intelligence agents from thousands of corporations, CNBC has learned exclusively. It’s one of the earliest instances of a major Wall Street bank opening its platforms to external AI tools. The move will allow clients’ autonomous agents to pull data and insights directly from the firm’s stock administration platforms, ShareWorks and Equity Edge, bypassing the traditional software interfaces built for human users, according to Mark Mitchell, chief product…

Read More

Senator Thom Tillis (R-NC) questions Secretary of Treasury Scott Bessent during a Senate Committee on Banking, Housing, and Urban Affairs hearing in Washington, DC on February 5, 2026.Nathan Posner | Anadolu | Getty ImagesRepublican Sen. Thom Tillis on Wednesday blasted President Donald Trump’s pick to lead the U.S. intelligence community as an “incendiary attack dog” and said he has no path to being confirmed by the Senate.The remarks on CNBC’s “Squawk Box” from the retiring North Carolina senator added to the growing backlash against Bill Pulte, the current head of the Federal Housing Finance Agency, whom Trump appointed acting director…

Read More

One might have a certain expectation about visiting an erotic novelist at home. I’ve learnt that it is often wholly misplaced (Jilly Cooper’s house in the Cotswolds was as spicy as a vicarage). And yet, as I walk through a Biennale-thronged Venice, with the sky quivering between bright sunshine and black thunderstorms, on my way to meet Lisa Hilton — the English historian, presenter and author of several lusty thrillers — I can’t help wondering what’s on the cards. Hilton scoops me up at her local vaporetto stop (Venice’s boat equivalent to a bus stop) to escort me to her garden flat off…

Read More

Here are Wednesday’s biggest calls on Wall Street: KeyBanc initiates DigitalOcean as overweight KeyBanc said the company’s playbook has “room to expand.” “We are initiating coverage of DigitalOcean with an Overweight rating and a $200 price target.” Goldman Sachs initiates Omnicom as buy Goldman said the advertising company is well positioned for growth. “Omnicom: It trades at an 18% FCF yield while core business is delivering organic growth. We are above consensus EBIT and FCF on higher margins.” RBC upgrades SSR Mining to outperform from sector perform RBC said it sees a slew of positive catalysts ahead for the mining…

Read More

The closest analog to what Blue Origin is attempting to do, therefore, concerns the rebuild of Space Launch Complex-40, which was largely destroyed by the AMOS-6 failure. According to Muratore, SpaceX was not allowed to begin reconstruction work at the launch pad until January 2017. The delay stemmed from the ongoing investigation, which included a grid-by-grid examination of debris, cataloging recovered materials, and launch site remediation. Muratore and other SpaceX engineers spent these four months redesigning the launch pad. SpaceX’s Falcon 9 rocket and Cargo Dragon spacecraft, seen here with the new launch tower and access arm at SLC-40. Credit:…

Read More

OpenAI chief Sam Altman will be attending the G7 conference in France later this month, CNBC has learned, as President Emmanuel Macron steps up efforts to court tech leaders across the globe in support of the country’s AI ambitions.France is hosting 2026’s G7 conference — an annual meeting of heads of state or government — from June 15-17, with AI expected to feature prominently on the agenda.Altman was invited by Macron to participate in the Leaders Summit, OpenAI told CNBC exclusively, in what would be the first time he’s attended. “The expectation is that he will be engaging in the…

Read More

Jacob Van Naarden is busy. In addition to running Eli Lilly’s oncology business, he’s now responsible for finding the drugmaker’s next opportunities as head of business development. And Lilly, now the world’s largest pharmaceutical company, is hungrier than ever for deals. “The company’s financial strength right now, driven mostly by the weight loss business, is so strong,” Van Naarden said in an interview at the American Society of Clinical Oncology’s annual meeting. “We have this really like almost generational opportunity to redeploy that capital in all of our disease areas to not only fuel growth for the company in the decades to…

Read More